FDA Investigator Rebecca Parrilla

Rebecca Parrilla has conducted inspections on 93 sites in 4 countries as of 13 Mar 2013. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
93
Last Inspection Date:
13 Mar 2013
Investigator Role:
FDA Investigator
Redica ID:
100000403
Countries of Inspections:
Puerto Rico, France, United Kingdom of Great Britain and Northern Ireland, Canada
FDA Investigators that have inspected at least one site in common with Rebecca Parrilla:
Abigail A Auster, Adalberto Cajigas, Adaliz Santaliz Cruz, Agnes M Santori, Alan A Rivera, Alicia M Mozzachio, Ana M Rivera, Anastasia M Shields, Andrea George, PhD, Angelica M Hernandez, Annette Melendez, Anthony C Warchut, Ariel Cruz Figueroa, Arlene M Badillo, Ashley N Queen, PhD, Azza Talaat, Barbara M Frazier, Brenda Rivera, Brenda S Zimmer, PhD, Burnell M Henry, Calvin B Koerner, Carlos A Medina, Carmelo Ross, Cassandra L Abellard, CDR Ileana Barreto Pettit, Charles D Brown, Cheryl A Clausen, Christopher Downey, PhD, Colleen F Hoyt, Colleen Thomas, PhD, Daniel L Obrzut, Dayna I Martinez, Dennis Cantellops Paite, Dianiris C Ayala, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Donald L Lech, Douglas W Gronski, Dov H Pluznik, PhD, Dr. Carmelo Rosa, Dr. Zhihao Qiu (Peter), PhD, Edwin Martinez, Eliezar Ramos, Enrique Galan, Eric L Dong, BS, Erika V Butler, Eva I Merced Medina, Frances L Dejesus, Frederick L Fricke, German Rivera, Hector Espinet, Hector Jcolon Torres, Iraida Ortiz, Israel Santiago, OCM, Ivis L Negron, Ivonne A Vicente, Jaime E Pares, Jason F Chancey, Javier O Vega, Jennifer Lalama, Jerri Baker, Joan M Cantellops Figueroa, Joe X Phillips, Joey V Quitania, Jorge E Martinez, Jorge L Gonzalez, Jorge L Guadalupe, Jorge L Lajara, Jose A Lopez, Jose A Moreno, Jose Acruz Gonzalez, José E Meléndez, Jose F Pedro, Jose M Cayuela, Jose R Lopez, Jose Rflores Veguilla, Jose Velez, Juan Rjimenez Garcia, Karen A Wolnik, Kathleen D Culver, Kent C Faul, Krishna Ghosh, PhD, Laiza V Garcia, Lareese K Thomas, Laura E Garcia, Laurimer Kuilan Torres, Leslie A Mendoza, Libia M Lugo, Lisa M Lopez, Loreily Figueroa Agrinsoni, Lourdes Andujar, LT Luis O Rodriguez, LT Rafael Gonzalez, Luis A Carrion, Luis Soto Lopez, Margarita Santiago, Maria Gutierrez Lugo, PhD, Marian E Ramirez, Marianela Aponte Cruz, Maribel V Juarbe, Maridalia Torres Irizarry, Marie F Morin, Marie T Falcone, Marilyn Santiago, Marta E Gonzalez, Masfin Abdi, Maxwell Van Tassell, PhD, Medina, Mendoza, Michael A Charles, Michael R Klapal, Michael Shanks, MS, Michelle Yclark Stuart, Miguel A Martinez Perez, Miguel Hernandez Sanchez, Milva E Melendez Perales, Minerva Rogers, Monica Cburgos Garcia, Mra Mcculloughj, Myriam M Sosa, Nancy Rosado, Neisa M Alonso, Nicholas L Paulin, Nicholas Obiri, PhD, Nicole E Knowlton, Nikolay Spiridonov, Noreen Muñiz, Nydia E Colon, Omotunde O Osunsanmi, Pablo Feliciano, Parul M Patel, Patricia F Hughes, PhD, Patricia H Dlugosz, Paul Z Balcer, Paula A Trost, Peter R Lenahan, Qin Xu, Rafael E Arroyo, Rafael E Cruz, Rafael Nevarez Nieves, Rakhi B Shah, Ramesh Potla, PhD, Ramon A Hernandez, Rapti D Madurawe, Raquel Gonzalez Rivera, Reba A Gates, Rebeca M Melendez, Rebecca E Dombrowski, Rebecca Rodriguez, Richard H Penta, Riley C Myers, PhD, Robert C Coleman, Robert Darius, Robert Sharpnack, Rosa J Motta, Rozelle G Smith, Russell J Glapion, Samina S Khan, Sandra A Hughes, Satheesh Thomas, Scott T Ballard, Sixto M Mercado Rios, Sonia M Monges, Stacie A Woods, Steven B Barber, Steven C Madzo, Steven Fong, MS, PhD, Tara G Bizjak, Teresa Jimenez, Thomas J Arista, Tiara Nbrown Crosen, Timothy Wadkin, PhD, Truong Xuan Nguyen (Andy), Victor S Pacheco, Vilmary Negron Rodriguez, Viviana Matta, Wanda J Torres, Wendy G Tan, PhD, William J Leonard, Yifan Wang, Ying Zhang, Youmin Wang, Yumi J Hiramine, Yvins Dezan, Yvonne E Lozano, Zachary L Stamm, Zhong Li, PhD

Rebecca Parrilla's Documents

Publish Date Document Type Title
November, 2006 FDA 483 Ivax Pharmaceuticals, Inc. - Form 483, 2006-11-14
May, 2007 EIR Pfizer Pharmaceuticals LLC - EIR, 2007-05-23
December, 2004 FDA 483 Schering Plough Products, LLC - Form 483, 2004-12-08
March, 2013 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2013-03-28
August, 2002 EIR Bristol-Myers Squibb Manufacturing Company Unlimited Company - EIR, 2002-08-08
June, 2000 FDA 483 Baxter Healthcare Corporation - Form 483, 2000-06-09
June, 2000 EIR Baxter Healthcare Corporation - EIR, 2000-06-09
May, 2005 FDA 483 Pfizer Pharmaceuticals LLC - Form 483, 2005-05-02
February, 2009 FDA 483 Auro PR Inc. - Form 483, 2009-02-27
December, 2005 FDA 483 Watson Laboratories Caribe, Inc. - Form 483, 2005-12-05
July, 2009 FDA 483 Lilly del Caribe, Inc. - Form 483, 2009-07-31
January, 2006 FDA 483 Smithkline Beecham (Cork) Inc. - Form 483, 2006-01-23
June, 2006 FDA 483 CEPH International Corporation - Form 483, 2006-06-02
May, 2005 EIR Amgen Manufacturing Limited LLC - EIR, 2005-05-20
September, 2003 FDA 483 Warner Chilcott Company, LLC - Form 483, 2003-09-17
November, 2010 FDA 483 McNeil Healthcare LLC. - Form 483, 2010-11-02
November, 2010 FDA 483 McNeil Healthcare, LLC - Form 483, 2010-11-02
July, 2000 EIR Pfizer Pharmaceuticals LLC - EIR, 2000-07-07
September, 2011 FDA 483 Galephar Pharmaceutical Research Inc - Form 483, 2011-09-29
June, 2004 FDA 483 Respi Care Group of Puerto Rico Inc. - Form 483, 2004-06-17
February, 2001 FDA 483 Schering-Plough Products L.L.C. - Form 483, 2001-02-16
November, 2007 FDA 483 Lilly del Caribe, Inc. - Form 483, 2007-11-02
April, 2005 EIR Cordis LLC - EIR, 2005-04-07
December, 2004 EIR Schering Plough Products, LLC - EIR, 2004-12-08
September, 2006 FDA 483 IPR Pharmaceuticals, Inc. - Form 483, 2006-09-21
November, 2004 FDA 483 Smithkline Beecham (Cork) Inc. - Form 483, 2004-11-05
March, 2013 EIR Patheon Puerto Rico, Inc. - EIR, 2013-03-28
December, 2005 EIR Watson Laboratories Caribe, Inc. - EIR, 2005-12-05
November, 2004 EIR Smithkline Beecham (Cork) Inc. - EIR, 2004-11-05
March, 2007 FDA 483 Smithkline Beecham (Cork) Inc. - Form 483, 2007-03-30
June, 2003 EIR INyX USA, Ltd. - EIR, 2003-06-23
August, 2003 EIR Patheon Puerto Rico, Inc. - EIR, 2003-08-14
December, 2003 EIR Cordis LLC - EIR, 2003-12-01
September, 2002 FDA 483 Alberto Culver (P.R.), Inc. - Form 483, 2002-09-30
May, 2005 FDA 483 Amgen Manufacturing Limited LLC - Form 483, 2005-05-20
December, 2002 EIR Patheon Puerto Rico, Inc. - EIR, 2002-12-17
December, 2009 FDA 483 Teva Puerto Rico LLC - Form 483, 2009-12-29
December, 2003 FDA 483 Cordis LLC - Form 483, 2003-12-01
April, 2005 FDA 483 Cordis LLC - Form 483, 2005-04-29
July, 2000 FDA 483 Pfizer Pharmaceuticals LLC - Form 483, 2000-07-07
July, 2003 EIR Monserrat Pharmaceuticals Inc. - EIR, 2003-07-18
August, 2002 FDA 483 Bristol-Myers Squibb Manufacturing Company Unlimited Company - Form 483, 2002-08-08
December, 2002 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2002-12-17
July, 2003 FDA 483 Monserrat Pharmaceuticals Inc. - Form 483, 2003-07-18
August, 2003 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2003-08-14
June, 2003 FDA 483 INyX USA, Ltd. - Form 483, 2003-06-23
September, 2007 FDA 483 Legacy Pharmaceuticals Puerto Rico, LLC - Form 483, 2007-09-28
August, 2005 FDA 483 IPR Pharmaceuticals, Inc - Form 483, 2005-08-16

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more